The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
The PTEN–PI3K pathway: of feedbacks and cross-talks
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M., Yeung, R. S., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
RetractedAKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1
Yuan, Z.-Q., Feldman, R. I., Sussman, G. E., Coppola, D., Nicosia, S. V., & Cheng, J. Q. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302674200 · Cited by 203
RetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Self-citationSabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Carracedo, A., Ma, L., Teruya-Feldstein, J., Rojo, F., Salmena, L., Alimonti, A., Egia, A., Sasaki, A. T., Thomas, G., Kozma, S. C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34739 · Cited by 1,381
Self-citationA transforming mutation in the pleckstrin homology domain of AKT1 in cancer
Carpten, J. D., Faber, A. L., Horn, C., Donoho, G. P., Briggs, S. L., Robbins, C. M., Hostetter, G., Boguslawski, S., Moses, T. Y., Savage, S., et al. (2007) · Nature · doi:10.1038/nature05933 · Cited by 1,292
Targeting the PI3K-Akt pathway in human cancer
Luo, J., Manning, B. D., & Cantley, L. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00248-4 · Cited by 1,290
Phosphorylation and Functional Inactivation of TSC2 by Erk
Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P., & Pandolfi, P. P. (2005) · Cell · doi:10.1016/j.cell.2005.02.031 · Cited by 1,268 · cited 2×
“Our group, along with the Cantley lab, recently demonstrated that Tsc2 heterozygous mice develop malignancies in which this feedback inhibition is overactive (Ma et al., 2005b; Manning et al., 2005).”
Self-citationPRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · cited 3×
“On the other hand, AKT phosphorylates and inhibits PRAS40 (proline-rich AKT substrate of 40KDa), which negatively regulates the activity of mTORC1 through the competition with the GTPase Rheb (Kovacina et al., 2003; Sancak et al., 2007; Vander Haar et al., 2007).”
BackgroundMayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230
Katso, R., Okkenhaug, K., Ahmadi, K., White, S., Timms, J., & Waterfield, M. D. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.615 · Cited by 1,204
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D.-H. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,190
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Biggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,113
Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00506-2 · Cited by 1,080
Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)
Zimmermann, S., & Moelling, K. (1999) · Science · doi:10.1126/science.286.5445.1741 · Cited by 1,078
Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A., & Downward, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80226-3 · Cited by 1,061
Insulin Activation of Rheb, a Mediator of mTOR/S6K/4E-BP Signaling, Is Inhibited by TSC1 and 2
Garami, A., Zwartkruis, F. J. T., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Kozma, S. C., Hafen, E., Bos, J. L., & Thomas, G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00220-x · Cited by 1,043
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,034
Self-citationCurrent development of mTOR inhibitors as anticancer agents
Faivre, S., Kroemer, G., & Raymond, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2062 · Cited by 1,000
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation
Sano, H., Kane, S., Sano, E., Mı̂inea, C. P., Asara, J. M., Lane, W. S., Garner, C. W., & Lienhard, G. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300063200 · Cited by 962
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Zhang, Y., Gao, X., Saucedo, L. J., Ru, B., Edgar, B. A., & Pan, D. (2003) · Nature Cell Biology · doi:10.1038/ncb999 · Cited by 923
Gao, T., Furnari, F., & Newton, A. C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.008 · Cited by 906
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., Ruiter, N. D. D., De Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 882
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Palomero, T., Sulis, M. L., Cortina, M., Real, P. J., Barnes, K., Ciofani, M., Caparros, E., Buteau, J., Brown, K., Perkins, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1636 · Cited by 877
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
TRB3: A tribbles Homolog That Inhibits Akt/PKB Activation by Insulin in Liver
Du, K., Herzig, S., Kulkarni, R. N., & Montminy, M. (2003) · Science · doi:10.1126/science.1079817 · Cited by 842
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Zhang, J., Grindley, J. C., Yin, T., Jayasinghe, S., He, X. C., Ross, J. T., Haug, J. S., Rupp, D., Porter-Westpfahl, K. S., Wiedemann, L. M., et al. (2006) · Nature · doi:10.1038/nature04747 · Cited by 817
Weinstein, I. B., & Joe, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3293 · Cited by 805
Sun, S.-Y., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., & Khuri, F. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0917 · Cited by 802
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
LoPiccolo, J., Blumenthal, G. M., Bernstein, W. B., & Dennis, P. A. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2007.11.003 · Cited by 801
Oncogenic PI3K deregulates transcription and translation
Bader, A. G., Kang, S., Zhao, L., & Vogt, P. K. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1753 · Cited by 798
Shah, O. J., Wang, Z., & Hunter, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.026 · Cited by 798
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
Wang, X. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4370 · Cited by 796
Defective STAT signaling by the leptin receptor in diabetic mice.
Ghilardi, N., Ziegler, S., Wiestner, A., Stoffel, R., Heim, M. H., & Skoda, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6231 · Cited by 793
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Negative Regulation of the Forkhead Transcription Factor FKHR by Akt
Tang, E. D., Nuñez, G., Barr, F. G., & Guan, K.-L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16741 · Cited by 761
Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
Rommel, C., Clarke, B. A., Zimmermann, S., Nuñez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D., & Glass, D. J. (1999) · Science · doi:10.1126/science.286.5445.1738 · Cited by 758
Nobukuni, T., Joaquin, M., Roccio, M., Dann, S. G., Kim, S. Y., Gulati, P., Byfield, M. P., Backer, J. M., Natt, F., Bos, J. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506925102 · Cited by 757
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
Wan, X., Harkavy, B., Shen, N., Grohar, P., & Helman, L. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209990 · Cited by 755
Spatial and Temporal Regulation of 3-Phosphoinositides by PI 3-Kinase and PTEN Mediates Chemotaxis
Funamoto, S., Meili, R., Lee, S., Parry, L., & Firtel, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00755-9 · Cited by 751
Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., & Blenis, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405659101 · Cited by 750
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
Self-citationS6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN
Wang, X., Trotman, L. C., Koppie, T., Alimonti, A., Chen, Z., Gao, Z., Wang, J., Erdjument-Bromage, H., Tempst, P., Cordon-Cardo, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.039 · Cited by 720
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, N., & Blenis, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700906200 · Cited by 702
The regulation and function of Class III PI3Ks: novel roles for Vps34
Backer, J. M. (2008) · Biochemical Journal · doi:10.1042/bj20071427 · Cited by 659
The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus
Torres, J., & Pulido, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009134200 · Cited by 629
Class I PI3K in oncogenic cellular transformation
Zhao, L., & Vogt, P. K. (2008) · Oncogene · doi:10.1038/onc.2008.244 · Cited by 594
Cloughesy, T. F., Yoshimoto, K., Nghiemphu, P., Brown, K., Dang, J., Zhu, S., Hsueh, T., Chen, Y., Wang, W., Youngkin, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050008 · Cited by 593
Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice
Gupta, S., Ramjaun, A. R., Haiko, P., Wang, Y., Warne, P. H., Nicke, B., Nye, E., Stamp, G., Alitalo, K., & Downward, J. (2007) · Cell · doi:10.1016/j.cell.2007.03.051 · Cited by 589
A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2
George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 559
Amino Acid and Insulin Signaling via the mTOR/p70 S6 Kinase Pathway
Tremblay, F., & Marette, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106703200 · Cited by 542
Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., & Unterman, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17184 · Cited by 540
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., Koon, H. B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C. L., & Kwiatkowski, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17222 · Cited by 538
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
Impaired Fas Response and Autoimmunity in Pten +/− Mice
Cristofano, A. D., Kotsi, P., Peng, Y. F., Cordon-Cardo, C., Elkon, K. B., & Pandolfi, P. P. (1999) · Science · doi:10.1126/science.285.5436.2122 · Cited by 521
Self-citationThe TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2
Huang, J., Dibble, C. C., Matsuzaki, M., & Manning, B. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00289-08 · Cited by 511
Hereditary cancer: Two hits revisited
Knudson, A. G. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01366952 · Cited by 491
Manning, B. D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408161 · Cited by 476
Drug discovery approaches targeting the PI3K/Akt pathway in cancer
Garcia-Echeverria, C., & Sellers, W. R. (2008) · Oncogene · doi:10.1038/onc.2008.246 · Cited by 473
Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases
Raught, B., Peiretti, F., Gingras, A., Livingstone, M., Shahbazian, D., Mayeur, G. L., Polakiewicz, R. D., Sonenberg, N., & Hershey, J. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600193 · Cited by 473
Nakae, J., Park, B.-C., & Accili, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15982 · Cited by 470
Tremblay, F., Brûlé, S., Hee Um, S., Li, Y., Masuda, K., Roden, M., Sun, X. J., Krebs, M., Polakiewicz, R. D., Thomas, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706517104 · Cited by 465 · cited 2×
“…can phosphorylate IRS-1 on a different residue, Ser1101, thus reducing its function and leading to insulin resistance in vivo in skeletal muscle (Tremblay et al., 2007). mTOR kinase itself might be able to phosphorylate this adaptor protein on Ser636/639 in certain circumstances (Ozes et al.,…”
BackgroundHerman, P. K., & Emr, S. D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.12.6742 · Cited by 444
Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308617100 · Cited by 436
Ozcan, U., Ozcan, L., Yilmaz, E., Düvel, K., Sahin, M., Manning, B. D., & Hotamisligil, G. S. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.023 · Cited by 435
Haruta, T. (2000) · Molecular Endocrinology · doi:10.1210/me.14.6.783 · Cited by 419
Tzatsos, A., & Kandror, K. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.63-76.2006 · Cited by 399
Identification of a tumour suppressor network opposing nuclear Akt function
Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature04809 · Cited by 394
Self-citationAlbuquerque, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.13.1549 · Cited by 392
Regulation of Raf-Akt Cross-talk
Moelling, K., Schad, K., Bosse, M., Zimmermann, S., & Schweneker, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111974200 · Cited by 387
Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38
Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q. J., Liu, Y., & Jiang, Y. (2007) · Science · doi:10.1126/science.1147379 · Cited by 382
Ozes, O. N., Akca, H., Mayo, L. D., Gustin, J. A., Maehama, T., Dixon, J. E., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051042298 · Cited by 382
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
Zhang, H., Bajraszewski, N., Wu, E., Wang, H., Moseman, A. P., Dabora, S. L., Griffin, J. D., & Kwiatkowski, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28984 · Cited by 381
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya-Feldstein, J., Cordon-Cardo, C., Celeste Simon, M., Rafii, S., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature05029 · Cited by 378
Self-citationAmino Acids Activate mTOR Complex 1 via Ca2+/CaM Signaling to hVps34
Gulati, P., Gaspers, L. D., Dann, S. G., Joaquin, M., Nobukuni, T., Natt, F., Kozma, S. C., Thomas, A. P., & Thomas, G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.002 · Cited by 370
Sasaki, A. T., Chun, C., Takeda, K., & Firtel, R. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406177 · Cited by 366
Identification of a Proline-rich Akt Substrate as a 14-3-3 Binding Partner
Kovacina, K. S., Park, G. Y., Bae, S. S., Guzzetta, A. W., Schaefer, E., Birnbaum, M. J., & Roth, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210837200 · Cited by 364
Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization
Fujita, N., Sato, S., Katayama, K., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203668200 · Cited by 358
Gu, J., Tamura, M., & Yamada, K. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.5.1375 · Cited by 334
Phosphoinositide 3‐kinase‐dependent activation of Rac
Welch, H. C. E., Coadwell, W. J., Stephens, L. R., & Hawkins, P. T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00454-x · Cited by 321
S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of Akt
Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Sahin, M., & Manning, B. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.019 · Cited by 308
Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model
Majumder, P. K., Yeh, J. J., George, D. J., Febbo, P. G., Kum, J., Xue, Q., Bikoff, R., Ma, H., Kantoff, P. W., Golub, T. R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232229100 · Cited by 285
Negative Regulation of the Serine/Threonine Kinase B-Raf by Akt
Guan, K.-L., Figueroa, C., Brtva, T. R., Zhu, T., Taylor, J., Barber, T. D., & Vojtek, A. B. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61518-8 · Cited by 281
Ni, Y. G., Wang, N., Cao, D. J., Sachan, N., Morris, D. J., Gerard, R. D., Kuro-o, M., Rothermel, B. A., & Hill, J. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610290104 · Cited by 279
Garlich, J. R., De, P., Dey, N., Su, J. D., Peng, X., Miller, A., Murali, R., Lu, Y., Mills, G. B., Kundra, V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-0669 · Cited by 279
Sistonen, L., Sarge, K. D., Phillips, B., Abravaya, K., & Morimoto, R. I. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4104 · Cited by 279
Wennström, S., & Downward, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4279 · Cited by 277
Schäfer, B., Gschwind, A., & Ullrich, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207278 · Cited by 266
Suppression of PTEN Expression by NF-κB Prevents Apoptosis
Vasudevan, K. M., Gurumurthy, S., & Rangnekar, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1007-1021.2004 · Cited by 246
Identification of the JNK Signaling Pathway as a Functional Target of the Tumor Suppressor PTEN
Vivanco, I., Palaskas, N., Tran, C., Finn, S. P., Getz, G., Kennedy, N. J., Jiao, J., Rose, J., Xie, W., Loda, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.021 · Cited by 245
Jakobsen, S. N., Hardie, D. G., Morrice, N., & Tornqvist, H. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100483200 · Cited by 238 · cited 2×
“, 2001; Tzatsos and Kandror, 2006), and other key regulators of this pathway can similarly modulate this adaptor protein (Jakobsen et al., 2001).”
BackgroundRegulation of nuclear translocation of Forkhead transcription factor AFX by protein kinase B
Takaishi, H., Konishi, H., Matsuzaki, H., Ono, Y., Shirai, Y., Saito, N., Kitamura, T., Ogawa, W., Kasuga, M., Kikkawa, U., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11836 · Cited by 238
Muscle-Specific Pten Deletion Protects against Insulin Resistance and Diabetes
Wijesekara, N., Konrad, D., Eweida, M., Jefferies, C., Liadis, N., Giacca, A., Crackower, M., Suzuki, A., Mak, T. W., Kahn, C. R., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1135-1145.2005 · Cited by 237
Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2
Manning, B. D., Logsdon, M. N., Lipovsky, A. I., Abbott, D., Kwiatkowski, D. J., & Cantley, L. C. (2005) · Genes & Development · doi:10.1101/gad.1314605 · Cited by 235
Almind, K., Inoue, G., Pedersen, O., & Kahn, C. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118705 · Cited by 231
G protein–independent Ras/PI3K/F-actin circuit regulates basic cell motility
Sasaki, A. T., Janetopoulos, C., Lee, S., Charest, P. G., Takeda, K., Sundheimer, L. W., Meili, R., Devreotes, P. N., & Firtel, R. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611138 · Cited by 227
PTEN signaling in brain: neuropathology and tumorigenesis
Endersby, R., & Baker, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.239 · Cited by 222
Tamburini, J., Chapuis, N., Bardet, V., Park, S., Sujobert, P., Willems, L., Ifrah, N., Dreyfus, F., Mayeux, P., Lacombe, C., et al. (2008) · Blood · doi:10.1182/blood-2007-03-080796 · Cited by 221
Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo
Fraser, M. M., Zhu, X., Kwon, C.-H., Uhlmann, E. J., Gutmann, D. H., & Baker, S. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2487 · Cited by 216
Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., & Olefsky, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2351 · Cited by 210
Fraser, M. M., Bayazitov, I. T., Zakharenko, S. S., & Baker, S. J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.048 · Cited by 202
Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1
Zhande, R., Mitchell, J. J., Wu, J., & Sun, X. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1016-1026.2002 · Cited by 202
Greene, M. W., Sakaue, H., Wang, L., Alessi, D. R., & Roth, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209153200 · Cited by 201
Heterotrimeric G-protein βγ-dimers in growth and differentiation
Schwindinger, W. F., & Robishaw, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204181 · Cited by 199
Phosphorylation of HDM2 by Akt
Ashcroft, M., Ludwig, R. L., Woods, D. B., Copeland, T. D., Weber, H. O., MacRae, E. J., & Vousden, K. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205276 · Cited by 197
A brief introduction to FOXOlogy
Burgering, B. M. T. (2008) · Oncogene · doi:10.1038/onc.2008.29 · Cited by 194
Kurlawalla-Martinez, C., Stiles, B., Wang, Y., Devaskar, S. U., Kahn, B. B., & Wu, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2498-2510.2005 · Cited by 191
Malanga, D., Scrima, M., De Marco, C., Fabiani, F., De Rosa, N., de Gisi, S., Malara, N., Savino, R., Rocco, G., Chiappetta, G., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5485 · Cited by 190
Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling
Radimerski, T., Montagne, J., Hemmings-Mieszczak, M., & Thomas, G. (2002) · Genes & Development · doi:10.1101/gad.239102 · Cited by 186
Regulation of Akt/PKB Ser473 Phosphorylation
Bayascas, J. R., & Alessi, D. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.020 · Cited by 184
Hsp90–Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis
Zhang, R., Luo, D., Miao, R., Bai, L., Ge, Q., Sessa, W. C., & Min, W. (2005) · Oncogene · doi:10.1038/sj.onc.1208548 · Cited by 174
Mabuchi, S., Ohmichi, M., Kimura, A., Hisamoto, K., Hayakawa, J., Nishio, Y., Adachi, K., Takahashi, K., Arimoto-Ishida, E., Nakatsuji, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204042200 · Cited by 174
Luo, J., Field, S. J., Lee, J. Y., Engelman, J. A., & Cantley, L. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503088 · Cited by 174
The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif
Walker, S. M., Leslie, N. R., Perera, N. M., Batty, I. H., & Downes, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20031839 · Cited by 167
Lindsay, Y. E., McCoull, D., Davidson, L., Leslie, N. R., Fairservice, A., Gray, A., Lucocq, J. M., & Downes, C. P. (2006) · Journal of Cell Science · doi:10.1242/jcs.000133 · Cited by 166
Wu, W., Wang, X., Zhang, W., Reed, W., Samet, J. M., Whang, Y. E., & Ghio, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303318200 · Cited by 166
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
Kim, M. S., Jeong, E. G., Yoo, N. J., & Lee, S. H. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604212 · Cited by 163
c-Jun promotes cellular survival by suppression of PTEN
Hettinger, K., Vikhanskaya, F., Poh, M. K., Lee, M. K., de Belle, I., Zhang, J.-T., Reddy, S. A. G., & Sabapathy, K. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401946 · Cited by 159
Regulation of Raf by Akt Controls Growth and Differentiation in Vascular Smooth Muscle Cells
Reusch, H. P., Zimmermann, S., Schaefer, M., Paul, M., & Moelling, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105322200 · Cited by 158
The p110δ isoform of PI 3‐kinase negatively controls RhoA and PTEN
Papakonstanti, E. A., Ridley, A. J., & Vanhaesebroeck, B. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601763 · Cited by 152
Yart, A., Laffargue, M., Mayeux, P., Chrétien, S., Peres, C., Tonks, N. K., Roche, S., Payrastre, B., Chap, H., & Raynal, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006966200 · Cited by 150
Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase
Wang, Q., Zhou, Y., Wang, X., & Evers, B. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209004 · Cited by 149
Ma, L., Teruya‐Feldstein, J., Bonner, P., Bernardi, R., Franz, D. N., Witte, D. P., Cordon‐Cardo, C., & Pandolfi, P. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4798 · Cited by 147
Self-citationRobust Neuronal Symmetry Breaking by Ras-Triggered Local Positive Feedback
Fivaz, M. L., Bandara, S., Inoue, T., & Meyer, T. (2008) · Current Biology · doi:10.1016/j.cub.2007.11.051 · Cited by 133
Possible mechanisms of disease development in tuberous sclerosis
Jóźwiak, J., Jóźwiak, S., & Wlodarski, P. K. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70411-4 · Cited by 132
Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells
Im, E., von Lintig, F. C., Chen, J. L., Zhuang, S., Qui, W., Chowdhury, S., Worley, P. F., Boss, G. R., & Pilz, R. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205792 · Cited by 130
Lahlou, H., Saint‐Laurent, N., Estève, J., Eychène, A., Pradayrol, L., Pyronnet, S., & Susini, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304524200 · Cited by 126
Pirola, L., Bonnafous, S., Johnston, A., Chaussade, C., Portis, F., & OBBERGHEN, E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208984200 · Cited by 121
Ma, L., Teruya‐Feldstein, J., Behrendt, N., Chen, Z., Noda, T., Hino, O., Cordon‐Cardo, C., & Pandolfi, P. P. (2005) · Genes & Development · doi:10.1101/gad.1314405 · Cited by 115
Self-citationOncogenic signaling of class I PI3K isoforms
Denley, A., Kang, S. G., Kärst, U., & Vogt, P. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210918 · Cited by 114
Xia, D., Srinivas, H., Ahn, Y., Sethi, G., Sheng, X., Yung, W. K. A., Xia, Q., Chiao, P. J., Kim, H., Brown, P. H., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610141200 · Cited by 114
Kim, S., Domon–Dell, C., Kang, J., Chung, D. H., Freund, J., & Evers, B. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308383200 · Cited by 110
Sato, S., Fujita, N., & Tsuruo, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402055200 · Cited by 109
Role of mTOR in the degradation of IRS‐1: Regulation of PP2A activity
Hartley, D., & Cooper, G. M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10135 · Cited by 106
The eIF4E RNA regulon promotes the Akt signaling pathway
Čuljković, B., Tan, K., Orolicki, S., Amri, A., Meloche, S., & Borden, K. L. B. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200707018 · Cited by 103
Serum- and Glucocorticoid-inducible Kinase SGK Phosphorylates and Negatively Regulates B-Raf
Zhang, B.-H., Tang, E., Zhu, T., Greenberg, M. E., Vojtek, A. B., & Guan, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102808200 · Cited by 103
Yee, W. M., & Worley, P. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.921 · Cited by 103
Denning, G., Jean-Joseph, B., Prince, C. Z., Durden, D. L., & Vogt, P. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210175 · Cited by 102
Karbowniczek, M., Cash, T. P., Cheung, M., Robertson, G. P., Astrinidis, A., & Henske, E. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402591200 · Cited by 97
Rheb Inhibits C-Raf Activity and B-Raf/C-Raf Heterodimerization
Karbowniczek, M., Robertson, G. P., & Henske, E. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605273200 · Cited by 83
Pi3 Kinase/Akt Pathway As A Therapeutic Target In Multiple Myeloma
Harvey, R. D., & Lonial, S. (2007) · Future Oncology · doi:10.2217/14796694.3.6.639 · Cited by 81
Rapamycin partially prevents insulin resistance induced by chronic insulin treatment
Berg, C. E., Lavan, B. E., & Rondinone, C. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00333-9 · Cited by 80
TGF-β signalling-related markers in cancer patients with bone metastasis
Baselga, J. M., Rothenberg, M. L., Tabernero, J. M., Seoane, J., Daly, T. M., Cleverly, A., Berry, B., Kloeker, S., RAY, C. A., Fill, J. A., et al. (2008) · Biomarkers · doi:10.1080/13547500701676019 · Cited by 76
Ras and Phosphoinositide 3-Kinase: Partners in Development and Tumorigenesis
Ramjaun, A. R., & Downward, J. (2007) · Cell Cycle · doi:10.4161/cc.6.23.4996 · Cited by 72
Yart, A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00144-0 · Cited by 68
Vasudevan, K. M., Burikhanov, R., Goswami, A., & Rangnekar, V. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1827 · Cited by 65
Luo, J., Sobkiw, C. L., Logsdon, N. M., Watt, J. M., Signoretti, S., O’Connell, F., Shin, E., Shim, Y., Pao, L. I., Neel, B. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504378102 · Cited by 58
Sampaio, C. S., Dance, M., Montagner, A., Édouard, T., Malet, N., Perret, B., Yart, A., Salles, J., & Raynal, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01318-07 · Cited by 57
Liu, J.-L., Mao, Z., LaFortune, T. A., Alonso, M. M., Gallick, G. E., Fueyo-Margareto, J., & Yung, W. K. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1263 · Cited by 54
Esposito, D. L., Li, Y., Vanni, C., Mammarella, S., Veschi, S., Loggia, F. D., Mariani‐Costantini, R., Battista, P., Quon, M. J., & Cama, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020933 · Cited by 54
The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4
Ahn, Y., Hwang, C. Y., Lee, S.-R., Kwon, K., & Lee, C. (2008) · Biochemical Journal · doi:10.1042/bj20071403 · Cited by 52
PTEN Regulation, a Novel Function for the p85 Subunit of Phosphoinositide 3-Kinase
Barber, D., Alvarado-Kristensson, M., Gonzalez-García, A., Pulido, R., & Carrera, A. (2006) · Science's STKE · doi:10.1126/stke.3622006pe49 · Cited by 43
Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cells
John T. Lee, Jr., Steelman, L. S., Chappell, W. H., & McCubrey, J. A. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5416 · Cited by 39
Wells, V. E., Downward, J., & Mallucci, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210580 · Cited by 29
Polymorphisms of the Insulin Receptor Subtrate-2 in Patients with Type 2 Diabetes
D’Alfonso, R., Marini, M. A., Frittitta, L., Sorge, R. P., Frontoni, S., Porzio, O., Mariani, L. M., Lauro, D., Gambardella, S., Trischitta, V., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020807 · Cited by 28
SnapShot: PTEN Signaling Pathways
Carracedo, A., Salmena, L., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.023 · Cited by 17
Self-citation
Cited by
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01827-6 · Cited by 2,138
Insulin Receptor Signaling in Normal and Insulin-Resistant States
Boucher, J., Kleinridders, A., & Kahn, C. R. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009191 · Cited by 1,473
The PI3K Pathway As Drug Target in Human Cancer
Courtney, K. D., Corcoran, R. B., & Engelman, J. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.3641 · Cited by 1,237
Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Polivka, J., & Janku, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.004 · Cited by 765
Metadata
- Authors
- Carracedo, A., & Pandolfi, P. P.
- Venue
- Oncogene
- Published
- 2008-09-15
- Volume
- 27
- Issue
- 41
- Pages
- 5527-5541
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2014096417
- Cited by
- 878
- References
- 185
- FWCI
- 19.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.